Related Experiment Video
Updated: Jun 21, 2026

06:38
In Vitro Modeling of Down Syndrome Neurogenesis Using Human-Induced Pluripotent Stem Cells
Published on: March 7, 2025
Increased lipid peroxidation in Down's syndrome mouse models
Keiichi Ishihara1, Kenji Amano, Eiichi Takaki
1Laboratory for Neurogenetics, RIKEN Brain Science Institute, Wako-shi, Saitama, Japan.
Journal of Neurochemistry
|August 4, 2009
Summary
Oxidative stress markers, like lipid peroxidation, are elevated in mouse models of Down
Area of Science:
- Neuroscience
- Genetics
- Biochemistry
Background:
- Down's syndrome (DS) is associated with elevated oxidative stress.
- Previous studies showed increased oxidative stress in cultured DS cells.
- In vivo evidence for increased oxidative stress in DS mouse models was lacking.
Purpose of the Study:
- To investigate in vivo oxidative stress and lipid peroxidation in DS mouse models.
- To identify proteins affected by oxidative stress in DS brains.
- To understand the contribution of oxidative stress to DS features.
Main Methods:
- Examined lipid peroxidation markers (13-HODEs, 4-HNE) in Ts1Cje and Ts2Cje mouse brains.
- Used oxidation-sensitive fluorescent probes to detect reactive oxygen species (ROS).
- Employed electron spin resonance (ESR) to assess antioxidant activity.
- Utilized mass spectrometry-based proteomics to identify modified proteins.
Main Results:
- Marked increases in protein modifications by 13-HODEs and 4-HNE were observed in Ts1Cje and Ts2Cje brains.
- Elevated reactive oxygen species (ROS) were detected in Ts1Cje brains.
- Antioxidant activity in Ts1Cje hippocampus remained unaffected, suggesting accelerated ROS production.
- Proteomics identified proteins involved in ATP generation, neuronal cytoskeleton, and antioxidant activity as targets of modification.
Conclusions:
- In vivo evidence confirms increased oxidative stress and lipid peroxidation in DS mouse models.
- Oxidative modification of key proteins may impair neuronal function and contribute to DS-related cognitive impairment.
- Findings highlight the role of accelerated ROS production in the pathophysiology of Down's syndrome.
